NVO - Eli Lilly Wants to Expand Access to Weight-Loss Treatments In Germany In Talks With Government | Benzinga
Eli Lilly And Co (NYSE:LLY) is reportedly engaged in discussions with the German government to lift the ban on the public health system covering the costs of weight-loss treatments.
The U.S. pharmaceutical giant, valued at around $600 billion, recently gained approval in the European Union for its weekly injection, Mounjaro, for weight loss in specific overweight or obese patients.
Mounjaro’s market introduction has been staggered, with launches in Germany, Poland, and Switzerland and an upcoming introduction in Britain.
Citing Spiegel magazine, Reuters noted that Representatives of the company are in a “good dialogue” with the federal ...